Autor(es): Ribeiro, João G. ; Ferreira, Amália S. ; Macedo, Sharon R.A. ; Rossi, Norton R.D.L.P. ; Silva, Mayara C.P. da ; Guerra, Rosane N.M. ; Nicolete, Roberto ; Barros, Neuza B. de
Data: 2017
Origem: Oasisbr
Assunto(s): Nanopartículas; Leishmaniose Cutânea; Leishmaniasis, Cutaneous
American tegumentary leishmaniasis (ATL) is considered a neglected disease, for which an e ff ective vaccine or an e ffi cient diagnosis is not yet available and whose chemotherapeutic arsenal is threatened by the emergence of resistance by etiological agents such as Leishmania amazonensis . ATL is endemic in poor countries and has a high incidence in Brazil. Vaccines developed from native parasite fractions have led to the identi fi cation of de fi ned antigenic subunits and the development of vaccine adjuvant technology. The purpose of the present study was to develop and compare preparations based on membrane antigens from L. amazonensis , as a biotechnological prototype for the immunoprophylaxis of the disease in a murine experimental model. For this purpose, batches of biodegradable polymeric micro/nanoparticles were produced, characterized and compared with other parasite's antigens in solution. All preparations containing membrane antigens presented low toxicity on murine macrophages. The in vivo evaluation of immunization e ffi cacy was performed against a challenge with L. amazonensis , along with an evaluation of the immune response pro fi le generated in BALB/C mice. The animals were followed for sample processing and quanti fi cation of serum-speci fi c cytokines, nitrites and antibodies. The sera of animals immunized with the non-encapsulated antigen formulations showed higher intensities of nitrites and total IgGs. This approach evidenced the importance of the biological studies involving the immune response of the host against the parasite being interconnected and related to the subfractionation of its proteins in the search for more e ff ective vaccine candidates.
